4Filed Aug 3, 8:00 PM ET

Core Laboratories (CLB) CEO Bruno Lawrence Buys 5,000 Shares

$CLB · Core Laboratories Inc. /DE/

Research Summary

AI-generated summary of this SEC filing

Updated

Core Laboratories (CLB) CEO Bruno Lawrence Buys 5,000 Shares

What Happened

  • Bruno Lawrence, Chairman and CEO (also a director) of Core Laboratories Inc. (CLB), reported a purchase of 5,000 shares on 2026-07-31. The shares were acquired at $10.78 per share for a total reported value of $53,900. The transaction is reported as a purchase (code P) and described as an "open market or private purchase."

Key Details

  • Transaction date: 2026-07-31
  • Price per share: $10.78
  • Shares purchased: 5,000
  • Total value: $53,900
  • Transaction code: P (Purchase); filing notes "open market or private purchase"
  • Form 4 filed: 2026-08-04 (Accession: 0001193125-26-331852; Period of Report: 2026-07-31)
  • Shares owned after transaction: not specified in the provided filing
  • Notable footnotes: none disclosed in the provided data
  • Timeliness: filing date provided; whether the report met the SEC’s 2-business-day Form 4 deadline is not specified here

Context

  • This was a direct share purchase (not an option exercise or award). Purchases by insiders can be viewed by investors as a positive signal because they increase the insider's ownership, but they do not guarantee future stock performance. No additional context (e.g., 10b5-1 plan or selling-to-cover tax withholding) was disclosed in the provided filing.